开窗腔内主动脉修复术中肠系膜上动脉扇贝形开窗选择性支架置入的作用
单中心回顾性分析2010年7月至2014年8月61例复杂腹主动脉瘤行开窗腔内修复术患者,39例使用肠系膜上动脉扇贝形开窗,其中11例(28%)置入支架、28例(72%)未置入。选择性支架置入组无支架狭窄或闭塞,未置入组出现3例肠系膜上动脉并发症,两组结局无统计学差异。
要点
- 肠系膜上动脉扇贝形开窗选择性支架置入的标准包括术中球囊测试发现开窗错位、扇贝形开窗合并单侧肾动脉开窗或支架、邻近开窗的血管存在狭窄。
- 39例中11例(28%)置入支架、28例(72%)未置入,平均随访21.7个月无支架血栓形成。
- 未置入组随访中出现3例肠系膜上动脉并发症、2例需再干预,无相关死亡;置入组术中发生1例分支相关并发症。
核心结论
- 开窗腔内主动脉修复术中,Zenith开窗支架的宽型肠系膜上动脉扇贝形开窗可按特定标准选择性置入支架并配合严密随访,不损害肠系膜上动脉的安全性和有效性。
研究设计与样本
- 单中心回顾性研究,纳入北卡罗来纳大学教堂山分校2010年7月至2014年8月前瞻性登记的行开窗腔内主动脉修复术的复杂腹主动脉瘤患者,仅分析使用肠系膜上动脉扇贝形开窗者,共39例,按扇贝形开窗是否置入支架分组比较。
主要发现
- 研究期间共61例患者接受治疗,平均年龄73岁,74.3%为男性;39例(63.9%)使用肠系膜上动脉扇贝形开窗,其中11例(28%)置入支架、28例(72%)未置入。
- 术后30天内死亡1例(2.5%),技术成功率和分支通畅率均为100%。
- 未置入组随访中出现3例肠系膜上动脉并发症,其中2例需再干预,无相关死亡;置入组术中发生1例分支相关并发症,长期随访无支架狭窄或闭塞。
- 平均随访21.7个月期间无肠系膜上动脉支架血栓形成,两组结局无统计学差异。
关键数值与推荐
- 扇贝形开窗置入支架的标准为满足以下一项或多项:术中球囊测试判定开窗错位;扇贝形开窗合并单侧肾动脉开窗或支架的构型;邻近开窗的血管存在狭窄。
- 根据Zenith开窗支架的使用说明,肠系膜上动脉扇贝形开窗的支架置入为可选操作。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Stenting of small fenestrations of the Zenith fenestrated endograft (ZFEN; Cook Medical, Bloomington, Ind) is necessary during fenestrated endovascular aneurysm repair (FEVAR) of complex abdominal aortic aneurysms to avoid malalignment. However, stenting of superior mesenteric artery (SMA) scallops of ZFEN devices is optional according to the instructions for use. The objective of this study was to assess the early and midterm outcomes of selective use of stents in SMA scallops of ZFEN during FEVAR procedures. METHODS: This study is a single-institution retrospective review of prospectively enrolled patients treated at the University of North Carolina at Chapel Hill between July 2010 and August 2014. Only patients with SMA scallops were included for analysis. We compared results between patients grouped as stented or unstented SMA scallops. The scallops were stented when one or more of the following criteria were present: misalignment of scallop determined by balloon testing intraoperatively; configuration consisting of an SMA scallop and a single renal fenestration or stent; and pre-existing stenosis in the vessel adjacent to the graft scallop. The study was approved by the local Institutional Review Board. Primary outcomes addressed were mortality, vessel patency, early and late complications, and reintervention rates. Baseline characteristics of the patients and procedure data were also described. RESULTS: During the 48-month study period, 61 patients were treated for complex abdominal aortic aneurysms at the University of North Carolina with a mean age of 73 years, and 74.3% of patients were male. Thirty-nine of 61 patients (63.9%) had a device design with an SMA scallop and were included for analysis. Eleven of 39 patients (28%) had the SMA primarily stented and 28 (72%) were unstented. There was only one death (2.5%) during the 30-day postoperative period, with 100% technical success and branch patency. In the unstented group, there were three SMA complications during follow-up, two requiring reintervention; however, there were no associated deaths. Among the stented group, there was one branch-related complication that occurred during the procedure but no stent stenosis or occlusion during the long-term follow-up. During the mean follow-up period of 21.7 months, no SMA stent thrombosis occurred. There was no statistical difference in outcomes between groups. CONCLUSIONS: Single-wide SMA scallops of ZFEN during FEVAR procedures may be selectively stented using specific criteria and rigorous follow-up, without compromising the safety and efficacy of the SMA.
引用
- Motta F, Vallabhaneni R, Kalbaugh CA, et al. The role of selective stenting for superior mesenteric artery scallops during fenestrated endovascular aneurysm repair. J Vasc Surg. 2018. PMID: 29960791. doi:10.1016/j.jvs.2018.05.016
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。